The Division of Nuclear Medicine at UPMC is currently accepting applications for a 1 year PET/CT fellowship program with a start date of July 1, 2019. Applicants must be eligible for unrestricted PA medical licensure and DEA license; have completed an ACGME approved nuclear medicine and/or radiology residency; and be board eligible or certified by the ABNM and/or ABR. The fellowship will provide highly supervised clinical training in both PET and diagnostic CT interpretation. In addition, research opportunities in the use of experimental PET radiopharmaceuticals in novel cancer therapy trials and the role of PET-CT and PET-MR imaging biomarkers for early cancer therapy response assessment are available.
UPMC is a world leader in research and development of both instrumentation (the first PET/CT scanner was invented at UPMC) and radiotracers (over 100 radiolabeled compounds for human and animal use, including Pittsburgh Compound B (PiB)). Animal resources include a pre-clinical PET/CT suite and state-of-the-art radiochemistry laboratory, Inveon small animal PET/CT (Siemens). Human resources include four GE PET/CT scanners (8- and 16-slice; two new 64-slice Discovery VCT), a Siemens HR+ brain PET scanner, and a Siemens mMR Biograph PET/MR system. In addition, a dedicated brain workstation is equipped with advanced SPM and normal database statistical software for analysis of dementia, epilepsy and brain tumor. UPMC is also equipped with advanced PACS system (Philips’ iSite).
The Department of Radiology at UPMC/University of Pittsburgh is one of the nation's largest and most productive academic radiology programs in the country. The Nuclear Medicine Division is a national leader in PET/CT clinical volumes and research. In addition to PET/CT, the Division has a comprehensive PET imaging center, which provides a full range of diagnostic and therapeutic nuclear medicine services.